loadpatents
Patent applications and USPTO patent grants for Gottardis; Marco.The latest application filed is for "methods of treating prostate cancer".
Patent | Date |
---|---|
Methods of Treating Prostate Cancer App 20220071980 - Gottardis; Marco ;   et al. | 2022-03-10 |
Methods of Treating Prostate Cancer App 20220071979 - Gottardis; Marco ;   et al. | 2022-03-10 |
Method of treating prostate cancer Grant 11,207,311 - Gottardis , et al. December 28, 2 | 2021-12-28 |
Psma And Steap1 Vaccines And Their Uses App 20210315986 - Gottardis; Marco ;   et al. | 2021-10-14 |
Bispecific EGFR/IGFIR binding molecules Grant 10,954,286 - Emanuel , et al. March 23, 2 | 2021-03-23 |
Multivalent Fibronectin Based Scaffold Domain Proteins App 20210017252 - CAMPHAUSEN; Ray ;   et al. | 2021-01-21 |
Method of treating cancer by administering multivalent fibronectin based scaffold domain proteins Grant 10,774,130 - Camphausen , et al. Sept | 2020-09-15 |
Prostate Neoantigens And Their Uses App 20200222478 - Bachman; Kurtis E. ;   et al. | 2020-07-16 |
Bispecific Egfr/igfir Binding Molecules App 20190153069 - EMANUEL; Stuart ;   et al. | 2019-05-23 |
Method Of Treating Prostate Cancer App 20190022079 - Gottardis; Marco ;   et al. | 2019-01-24 |
Polynucleotides encoding bispecific EGFR/IGF-IR binding molecules Grant 10,183,987 - Emanuel , et al. Ja | 2019-01-22 |
Multivalent Fibronectin Based Scaffold Domain Proteins App 20180265572 - CAMPHAUSEN; Ray ;   et al. | 2018-09-20 |
Multivalent fibronectin based scaffold domain proteins Grant 9,902,762 - Camphausen , et al. February 27, 2 | 2018-02-27 |
Bispecific Egfr/igfir Binding Molecules App 20180037631 - EMANUEL; Stuart ;   et al. | 2018-02-08 |
Methods of Treating Prostate Cancer App 20180028521 - Gottardis; Marco ;   et al. | 2018-02-01 |
Method of treating cancer by administering EGFR and EGFR/IGFIR binding molecules Grant 9,771,411 - Emanuel , et al. September 26, 2 | 2017-09-26 |
Bispecific Egfr/igfir Binding Molecules App 20150259398 - EMANUEL; Stuart ;   et al. | 2015-09-17 |
Bispecific EGFR/IGFIR binding molecules Grant 9,017,655 - Emanuel , et al. April 28, 2 | 2015-04-28 |
Multivalent Fibronectin Based Scaffold Domain Proteins App 20140349929 - CAMPHAUSEN; Ray ;   et al. | 2014-11-27 |
Multivalent fibronectin based scaffold domain proteins Grant 8,728,483 - Camphausen , et al. May 20, 2 | 2014-05-20 |
Bispecific Egfr/igfir Binding Molecules App 20130157948 - EMANUEL; Stuart ;   et al. | 2013-06-20 |
Multivalent Fibronectin Based Scaffold Domain Proteins App 20130012435 - Camphausen; Ray ;   et al. | 2013-01-10 |
Bispecific EGFR/IGFIR binding molecules Grant 8,343,501 - Emanuel , et al. January 1, 2 | 2013-01-01 |
Multivalent fibronectin based scaffold domain proteins Grant 8,221,765 - Camphausen , et al. July 17, 2 | 2012-07-17 |
Bispecific Egfr/igfir Binding Molecules App 20100179094 - Emanuel; Stuart ;   et al. | 2010-07-15 |
Multivalent Fibronectin Based Scaffold Domain Proteins App 20090299040 - CAMPHAUSEN; RAY ;   et al. | 2009-12-03 |
Polynucleotides encoding human histone deacetylase HDAC9c Grant 7,199,227 - Jackson , et al. April 3, 2 | 2007-04-03 |
Novel human histone deacetylases App 20060269559 - Jackson; Donald G. ;   et al. | 2006-11-30 |
Methods for identifying or screening for agents that modulate 17.beta.-HSD3 Grant 7,138,246 - Lorenzi , et al. November 21, 2 | 2006-11-21 |
Methods for identifying or screening for agents that modulate 17beta-HSD3 App 20050191707 - Lorenzi, Matthew V. ;   et al. | 2005-09-01 |
Transgenic non-human mammals expressing a reporter nucleic acid under the regulation of androgen response elements App 20040068762 - Attar, Ricardo M. ;   et al. | 2004-04-08 |
Compositions and methods for treatment of hyperproliferative diseases Grant 6,624,154 - Benoit , et al. September 23, 2 | 2003-09-23 |
Novel human histone deacetylases App 20030161830 - Jackson, Donald G. ;   et al. | 2003-08-28 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.